Role of cytokines in the destruction of acinar structure in Sjogren's syndrome salivary glands

Laboratory Investigation

Volumn 77, Issue 3, 1997, Pages 269-280

  Azuma, Masayuki ^a   Motegi, Katsumi ^a   Aota, Keiko ^a   Hayashi, Yoshio ^a   Sato, Mitsunobu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALPASTATIN; CYTOKINE; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ACINAR CELL; ARTICLE; CELL CLONE; CONTROLLED STUDY; DESTRUCTION; HUMAN; HUMAN CELL; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; SALIVARY GLAND; SJOEGREN SYNDROME;

CLONE CELLS; CYTOKINES; GELATINASES; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; NF-KAPPA B; PEPTIDE HYDROLASES; PROTEASE INHIBITORS; PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, INTERLEUKIN-1; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; SALIVARY GLANDS; SJOGREN'S SYNDROME; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS;

EID: 0030757716     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Adamson TC III, Fox RI, Frisman DM, and Howell FV (1983). Immunohistochemical analysis of lymphoid infiltrates in primary Sjögren's syndrome using monoclonal antibodies. J Immunol 130:203-208.
2. Alspaugh MA, Whaley WW, Wohl MJ, and Bunin JJ (1981). Sjögren's syndrome. In: Kekkey WN, Harris ED Jr, Ruddy S, and Sledge CB, editors. Textbook of rheumatology. Philadelphia: WB Saunders, 971-999.
3. Andersen LG and Talal N (1971). The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome. Clin Exp Immunol 9:199-211.
4. Arend WP and Dayer J-M (1995). Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 38:151-160.
5. Azuma M, Tamatani T, Fukui K, Bando T, and Sato M (1994). Enhanced proteolytic activity is responsible for the aberrant morphogenetic development of SV40-immortalized normal human salivary gland cells grown on basement membrane components. Lab Invest 70:217-227.
6. Azuma M, Tamatani T, Fukui K, Yoshida H, Kamogashira T, Ogino K, Suzuki T, and Sato M (1993a). Role of plasminogen activators, metalloproteinases and the tissue inhibitor of metalloproteinase-1 in the metastatic process of human salivary gland adenocarcinoma cells. Int J Cancer 54:669-676.
7. - mutant DNA. Lab Invest 69:24-42.
8. Bacharach E, Itin A, and Keshet E (1992). In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc Natl Acad Sci USA 89:10686-10690.
9. Banerjee SD, Cohn RH, and Bernfield MR (1977). The basal lamina of embryonic salivary epithelia: Production by the epithelium and role in maintaining lobular morphology. J Cell Biol 73:445-463.
10. Bauerele PA and Henkel T (1994). Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141-179.
11. Beauparlant P, Kwan I, Bitar R, Chou P, Koromilas AE, Sonenberg N, and Hiscott J (1994). Disruption of IκB-α regulation by antisense RNA expression leads to malignant transformation. Oncogene 9:3189-3197.
12. Bernfield M, Banerjee SD, and Cohn RH (1972). Dependence of salivary epithelial morphology and branching morphogenesis upon acid mucopolysaccharide protein (proteoglycan) at the epithelial surface. J Cell Biol 52:674-689.
13. Brown PD, Levy AT, Margulies IMK, Liotta LA, and Stetler-Stevenson WG (1990). Independent expression and cellular processing of Mr 72:000 type IV collagenase and interstitial collagenase in human tumorigenetic cell lines. Cancer Res 50: 6184-6191.
14. Chan H and Aggarwal BB (1994). Role of tumor necrosis factor receptors in the activation of nuclear factor κB in human histiocytic lymphoma U-937 cells. J Biol Chem 269: 31424-31429.
15. Claudio E, Segada F, Wrobel K, Ramos S, Bravo R, and Lazo PS (1996). Molecular mechanism of TNFα cytotoxicity: Activation of NF-κB and nuclear translocation. Exp Cell Res 224:63-71.
16. Daniel TE (1984). Labial salivary gland biopsy in Sjögren's syndrome. Arthritis Rheum 27:147-156.
17. 2 production by human synovial cells and dermal fibroblasts. J Exp Med 162:2163-2168.
18. Feinberg AP and Vogelstein B (1984). A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 137:266-267.
19. Fox RI, Kang H-I, Ando D, Abrams J, and Pisa E (1994). Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol 152:5532-5539.
20. Ganser GE, Stricklin GP, and Matrisian LM (1991). EGF and TGFα influence in vitro lung development by the induction of matrix-degrading metalloproteinases. Int J Dev Biol 35:453-461.
21. Goldring MB, Birkhead JR, Suen L-F, Yamin R, Mizuno S, Glowacki J, Arbiser JL, and Apperley JF (1994). Interleukin-1β-modulated gene expression in immortalized human chondrocytes. J Clin Invest 94:2307-2316.
22. Hamano H, Saito I, Haneji N, Mitsuhashi Y, Miyasaka N, and Hayashi Y (1993). Expression of cytokine genes during development of autoimmune sialadenitis in MRL/Ipr mice. Eur J Immunol 23:2387-2391.
23. Heller RA and Krönke M (1994). Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol 126:5-9.
24. Henke A, Mohr C, Sprenger H, Graebner C, Sterlzer A, Nain M, and Gemsa D (1992). Coxsackievirus B3-induced production of tumor necrosis factor-α, IL-1β, and IL-6 in human monocytes. J Immunol 148:2270-2277.
25. Hsu SM, Raine L, and Sanger H (1981). The use of a avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580.
26. Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB-M, Mueller-Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA, and Peyron J-F (1996). Tyrosine phosphorylation of IκK-α activates NF-κB without proteolytic degradation of IκB-α. Cell 86:787-798.
27. Korczak B, Kerbel RS, and Dennis J (1991). Constitutive expression and secretion of proteases in non-metastatic SP1 mammary carcinoma cells and its metastatic sublines. Int J Cancer 48:557-561.
28. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
29. Liou HC and Baltimore D (1993). Regulation of the NF-κB/rel transcription factor and IκB inhibitor system. Curr Opin Cell Biol 5:477-487.
30. MacNaul KL, Chartrain N, Lark M, Tocci MJ, and Hutchinson NI (1990). Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinase-1 in rheumatoid human synovial fibroblasts. J Biol Chem 265:17238-17245.
31. Matrisian LM (1992). The matrix degrading metalloprotein-ases. Bioessays 14:455-463.
32. Millis AJT, Hoyle M, McCue HM, and Martini H (1992). Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Exp Cell Res 201:373-379.
33. Miyamoto S, Maki M, Schmitt MJ, Hatanaka M, and Verma IM (1994). Tumor necrosis factor α-induced phosphorylation of IκBα is a signal for its degradation but not dissociation from NF-κB. Proc Natl Acad Sci USA 91:12740-12744.
34. Montesano R, Pepper MS, Mohle-Steinlein U, Risau W, Wagner EF, and Orci L (1990). Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell 62: 435-445.
35. Narayanan R, Higgins KA, Perez JR, Coleman T, and Rosen C (1993). Evidence for differential functions of the p50 and p65 subunits of NF-κB with a cell adhesion model. Mol Cell Biol 13:3802-3810.
36. Perkins ND, Edwards NL, Duckett CS, Agranoff AB, Schmid RM, and Nabel GJ (1993). A cooperative interaction between NF-κB and SP-1 is required for HIV-1 enhancer activation. EMBO J 12:3551-3558.
37. Rosai J (1996). Major and minor salivary glands. In: Rosai J, editor. Ackerman's surgical pathology. New York: Mosby-Year Book, 815-818.
38. Sambrook J, Fritsch EF, and Maniatis T (1989). Extraction, purification, and analysis of messenger RNA from eukaryotic cells. In: Molecular cloning, a laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
39. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, and Seiki M (1994). A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61-65.
40. Schultz RM, Silberman S, Persky B, Bajkowski AS, and Carmichael DF (1988). Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res 48:5539-5545.
41. Shearn MA (1971). Sjögren's syndrome. Philadelphia: WB Saunders, 12-14.
42. Stein B, Baldwin AS Jr, Ballard DW, Greene WC, Angel P, and Herrlich P (1993a). Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J 12:3879-3891.
43. Stein B, Cogswell PC, and Baldwin AS Jr (1993b). Functional and physical associations between NF-κB and C/EBP family members: A Rel domain-bZIP interaction. Mol Cell Biol 13:3964-3974.
44. Stetler-Stevenson WG, Krutzsch HC, and Liotta LA (1989). Tissue inhibition of metalloproteinase (TIMP-2): A new member of the metalloproteinase inhibitory family. J Biol Chem 264:17374-17378.
45. Talal N and Bunim JJ (1964). The development of malignant lymphoma in the course of Sjögren's syndrome. Am J Med 36:529-540.
46. Towbin H, Staehlin T, and Gordon J (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and applications. Proc Natl Acad Sci USA 76:4350-4353.
47. Welgus HG, Campbell EJ, Bar-Shavit Z, Senior RM, and Teitelbaum SL (1985). Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. J Clin Invest 76:219-224.
48. Yamaguchi F, Saya H, Bruner JM, and Morrison RS (1994). Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc Natl Acad Sci USA 91:484-488.
49. Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL, and Rao JS (1996). Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 56:384-392.
50. Yang ET and Moses HL (1990). Transforming growth factor β1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 111:731-741.
51. Yssel H, Shanafelt MS, Soderberg C, Schneider PV, Anzola J, and Peltz G (1991). Borrelia burgdorferi activates a T helper type-1 like T cell subset in Lyme arthritis. J Exp Med 174:593-601.
52. Zabel U, Henkel T, dos Santos Silva M, and Baeuerle PA (1993). Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus. EMBO J 12:201-211.